Can I read Chemotherapy for Patients with Advanced Lung Cancer with Interstitial Lung Disease: a Prospective Observational Study on EtoBox?

Chemotherapy for Patients with Advanced Lung Cancer with Interstitial Lung Disease: a Prospective Observational Study by Keigo Koda; Yasunori Enomoto; Yoichiro Aoshima; Yusuke Amano; Shinpei Kato; Hirotsugu Hasegawa; Takashi Matsui; Koshi Yokomura; Eisuke Mochizuki; Shun Matsuura; Naoki Koshimizu; Meiko Morita; Suguru Kojima; Ayano Watanabe; Yoshiyuki Oyama; Masaki Ikeda; Hideki Kusagaya; Tomohiro Uto; Jun Sato; Shiro Imokawa; Masato Kono; Dai Hashimoto; Yosuke Kamiya; Mikio Toyoshima; Kazuhiro Asada; Masako Morita; Masashi Mikamo; Hideki Yasui; Hironao Hozumi; Masato Karayama; Yuzo Suzuki; Kazuki Furuhashi; Tomoyuki Fujisawa; Noriyuki Enomoto; Yutaro Nakamura; Naoki Inui; Takafumi Suda is a Medicine article available to read on EtoBox.

What is Chemotherapy for Patients with Advanced Lung Cancer with Interstitial Lung Disease: a Prospective Observational Study about?

## Introduction: Although recent advances in chemotherapy for lung cancer are remarkable, most clinical trials have excluded patients with interstitial lung disease (ILD) due to the concern of developing acute exacerbation (AE) of ILD. Hence, accumulating original evidence of cancer treatment for this population is important. ## Methods: Between 2016 and 2020, a prospective observational study was conducted across 11 Japanese hospitals. Patients with chemotherapy-__naïve__, inoperable, advanced lung cancer with ILD were included. The primary outcome was the frequency of AE-ILD after registration; the secondary outcomes were the risk factor of AE-ILD and the efficacy of chemotherapy. ## Results: Among 124 patients enrolled, 109 patients who received chemotherapy were analyzed. The median age was 72 years, and the majority showed usual interstitial pneumonia (UIP)/probable UIP pattern upon chest computed tomography. The median percent-predicted forced vital capacity (%FVC) was 81% (interquartile range: 66–95%). After registration, 23 patients (21.1%; 95% confidence interval [CI]: 14.4–29.7%) developed AE-ILD. The logistic analysis revealed that lower %FVC slightly but significantly i

Who reads Chemotherapy for Patients with Advanced Lung Cancer with Interstitial Lung Disease: a Prospective Observational Study?

Author

Keigo Koda; Yasunori Enomoto; Yoichiro Aoshima; Yusuke Amano; Shinpei Kato; Hirotsugu Hasegawa; Takashi Matsui; Koshi Yokomura; Eisuke Mochizuki; Shun Matsuura; Naoki Koshimizu; Meiko Morita; Suguru Kojima; Ayano Watanabe; Yoshiyuki Oyama; Masaki Ikeda; Hideki Kusagaya; Tomohiro Uto; Jun Sato; Shiro Imokawa; Masato Kono; Dai Hashimoto; Yosuke Kamiya; Mikio Toyoshima; Kazuhiro Asada; Masako Morita; Masashi Mikamo; Hideki Yasui; Hironao Hozumi; Masato Karayama; Yuzo Suzuki; Kazuki Furuhashi; Tomoyuki Fujisawa; Noriyuki Enomoto; Yutaro Nakamura; Naoki Inui; Takafumi Suda

Published

2022

Language

EN

Field

Medicine (Health Sciences)